Table 3 Distribution of HR-HPV genotypes in study participants
HPV type | Single infection | Double infections | Multiple infections | Total infections | |||
|---|---|---|---|---|---|---|---|
Positive no | % (95% CI) | Positive no | % (95% CI) | Positive no | % (95% CI) | % (95% CI) | |
HPV16 | 380 | 2.4 (2.2–2.7) | 184 | 1.2 (1.0–1.3) | 105 | 0.7 (0.5–0.8) | 4.3 (4.0–4.6) |
HPV52 | 185 | 1.2 (1.0–1.4) | 98 | 0.6 (0.5–0.8) | 269 | 1.7 (1.5–1.9) | 3.5 (3.2–3.8) |
HPV58 | 144 | 0.9 (0.8–1.1) | 106 | 0.7 (0.5–0.8) | 61 | 0.4 (0.3–0.5) | 2.0 (1.8–2.2) |
HPV53 | 138 | 0.9 (0.7–1.0) | 81 | 0.5 (0.4–0.6) | 59 | 0.4 (0.3–0.5) | 1.8 (1.6–2.0) |
HPV39 | 95 | 0.6 (0.5–0.7) | 90 | 0.6 (0.5–0.7) | 45 | 0.3 (0.2–0.4) | 1.5 (1.3–1.7) |
HPV51 | 88 | 0.6 (0.4–0.7) | 69 | 0.4 (0.3–0.5) | 61 | 0.4 (0.3–0.5) | 1.4 (1.2–1.6) |
HPV18 | 96 | 0.6 (0.5–0.7) | 32 | 0.2 (0.1–0.3) | 40 | 0.3 (0.2–0.3) | 1.1 (0.9–1.2) |
HPV33 | 74 | 0.5 (0.4–0.6) | 53 | 0.3 (0.2–0.4) | 32 | 0.2 (0.1–0.3) | 1.0 (0.9–1.2) |
HPV31 | 70 | 0.4 (0.3–0.6) | 46 | 0.3 (0.2–0.4) | 29 | 0.2 (0.1–0.3) | 0.9 (0.8–1.1) |
HPV68 | 57 | 0.4 (0.3–0.5) | 38 | 0.2 (0.2–0.3) | 27 | 0.2 (0.1–0.2) | 0.8 (0.6–0.9) |
HPV66 | 55 | 0.4 (0.3–0.4) | 31 | 0.2 (0.1–0.3) | 33 | 0.2 (0.1–0.3) | 0.8 (0.6–0.9) |
HPV56 | 43 | 0.3 (0.2–0.4) | 33 | 0.2 (0.1–0.3) | 35 | 0.2 (0.1–0.3) | 0.7 (0.6–0.8) |
HPV59 | 27 | 0.2 (0.1–0.2) | 20 | 0.1 (0.1–0.2) | 23 | 0.1 (0.1–0.2) | 0.4 (0.3–0.6) |
HPV45 | 38 | 0.2 (0.2–0.3) | 10 | 0.1 (0.0–0.1) | 10 | 0.1 (0.0–0.1) | 0.4 (0.3–0.5) |
HPV35 | 18 | 0.1 (0.1–0.2) | 10 | 0.1 (0.0–0.1) | 12 | 0.1 (0.0–0.1) | 0.3 (0.2–0.3) |
HPV82 | 14 | 0.1 (0.0–0.1) | 15 | 0.1 (0.0–0.1) | 8 | 0.1 (0.0–0.1) | 0.2 (0.2–0.3) |
HPV26 | 15 | 0.1 (0.0–0.1) | 13 | 0.1 (0.0–0.1) | 5 | 0.0 (0.0–0.1) | 0.2 (0.1–0.3) |